— Know what they know.
Not Investment Advice

CANQF OTC

CanaQuest Medical Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -99.3% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 54 · $2121 mcap · 9M float · 0.0001% daily turnover · Short 80% of daily vol

Balance Sheet Trends

Total Assets
$215K +52.4% ▲
5Y CAGR: +14.3%
Total Liabilities
$1M +15.1% ▲
5Y CAGR: +6.9%
Shareholders Equity
-$1M -9.9% ▼
Cash & Investments
$78 -98.1% ▼
5Y CAGR: +57.7%
Total Debt
$376K -40.8% ▼
5Y CAGR: +19.6%
Net Debt
$376K -40.5% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$422$2K$17K$4K$78
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$422$2K$17K$4K$78
Net Receivables$31K$7K$2K$5K$23K
Inventory$0$0$0$0$0
Other Current Assets$3K$0$0$0$0
Total Current Assets$34K$11K$50K$118K$212K
Property, Plant & Equip.$14K$12K$20K$23K$2K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$14K$12K$20K$23K$2K
Total Assets$48K$23K$70K$141K$215K
— Liabilities —
Accounts Payable$0$0$0$0$0
Short-Term Debt$107K$201K$346K$635K$376K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$445K$473K$411K$513K$946K
Total Current Liabilities$552K$673K$757K$1M$1M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$552K$673K$757K$1M$1M
— Equity —
Common Stock$4M$5M$5M$6M$6M
Retained Earnings-$7M-$8M-$8M-$11M-$13M
Accumulated OCI$179K$252K$240K$522K$836K
Total Stockholders Equity-$504K-$650K-$687K-$1M-$1M
Total Liabilities & Equity$48K$23K$70K$141K$215K
— Key Metrics —
Total Debt$107K$201K$346K$635K$376K
Net Debt$106K$199K$329K$631K$376K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms